1

Sinocare

Sinocare
Leadership team

Mr. Shao Bo Li (Chairman & GM)

Mr. An Guo Huang (CFO & Sec. of the Board)

Mr. Shi Min Wang (Deputy Gen. Mang.)

Products/ Services
Biotechnology, Manufacturing, Sensor
Number of Employees
1,000 - 20,000
Headquarters
Changsha, Jiangsu, China
Established
2002
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
SZSE:300298
Social Media
Overview
Location
Summary
Sinocare Inc. engages in the development, manufacture, and marketing of diagnosis rapid testing products primarily in the People's Republic of China. It offers SARS-CoV-2 antibody test strip; Safe-Accu blood glucose monitoring systems; Safe-AQ blood glucose monitoring systems; Gold-Accu blood glucose monitoring systems; Safe-Accu UG blood, glucose, and uric acid monitoring systems; Safe-Accu KG blood, glucose, and ketone monitoring systems; and D Nurse mobile glucose meters. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals. It also exports its products to 135 countries. Sinocare Inc. was founded in 2002 and is based in Changsha, the People's Republic of China.
History

Sinocare was founded in 1981, in Alameda, California, as a research and development company dedicated to advancing the science of diabetes care and management. As technology and the diabetes industry evolved, Sinocare expanded its business, introducing new products and services to meet the changing needs of the diabetes community. Today, Sinocare is a leading manufacturer of diabetes care and management products, including meters, testing strips and lancets, with a commitment to developing innovative solutions for diabetes patients and healthcare professionals.

Mission
Our mission is to provide top-quality and advanced diabetes products at an affordable price to our customers. We strive to be the trusted choice of healthcare providers and individuals, offering innovative and reliable diabetes solutions.
Vision
We strive to be the preferred provider of value-based diabetes solutions, providing the highest quality products and services to our customers and promoting a healthy lifestyle for all those affected by diabetes.
Key Team

Mr. Jianwen Cai (Deputy Gen. Mang.)

Mr. Baishen Ouyang (Chairman of the Supervisory Board & Assistant to the GM)

Mr. Chungeng Chen (Supervisor & Purchasing Director)

Recognition and Awards
Sinocare has been recognized for its innovation and commitment to diabetes care and management with several international awards, including the World Health Organization’s Gold Quality Seal, the Medical Device and Diagnostics Industry Association’s Excellence in Quality Award, and the Golden Diabetes Care Award.
References

Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.

Sinocare
Leadership team

Mr. Shao Bo Li (Chairman & GM)

Mr. An Guo Huang (CFO & Sec. of the Board)

Mr. Shi Min Wang (Deputy Gen. Mang.)

Products/ Services
Biotechnology, Manufacturing, Sensor
Number of Employees
1,000 - 20,000
Headquarters
Changsha, Jiangsu, China
Established
2002
Net Income
20M - 100M
Revenue
100M - 500M
Traded as
SZSE:300298
Social Media